forgot password?

  • Visitor Edition

 

Health Care, Pharmaceuticals  Article, pets
Premium Content
Article at a glance:

Pharma for Fido

The worldwide market for pet products and services is already substantial and growing fast, and pet owners show little price sensitivity for animal medications. A combination of increasingly wealthy consumers and aging pets, plus new drugs for animals to treat conditions such as arthritis and heart failure, is adding to the market’s attractions.

The take-away
Big pharmaceutical companies considering whether to divest their animal health subsidiaries may want to take a second look at the potential of pet health care.

This article is available to Premium Members only.

Explore "Additional Thinking" to find hundreds of related, free articles.

Additional Thinking

This Week's Featured Article

US investment banks are cutting costs by shrinking employment, but they can trim other types of spending without causing serious damage to their culture or morale.

Search full site

This article is available to Premium Members only. Please subscribe below.

Already a Quarterly member? Log in now.
Are you a Firm member or alumnus?

Premium Membership benefits:

  • Unlimited site access, including McKinsey's latest thinking and enduring business ideas from the archive
  • Subscription to the collector's edition print journal
  • Downloadable PDFs of all articles for offline use

Premium Membership FAQs

Start by filling in this form

  • 1. Membership Information
  • 2. Shipping, Billing, & Payment
  • 3. Review & Complete

Country & Membership Term

Shipping & Handling covers all charges for your membership term.

You may pay with Visa, MasterCard, Discover, or American Express.

Member Information

View our privacy policy.

We will not share your e-mail.
See details.

Newsletter Sign-up

*Required